1
项与 Anti-BCMA|PD-L1 CAR-T (Chinese People's Liberation Army General Hospital) 相关的临床试验Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma
This is a single center, non-randomized, open-label, phase 2 study to evaluate the efficacy and safety of BCMA-PD1-CART cells therapy for patients with relapsed/refractory Multiple Myeloma.
100 项与 Anti-BCMA|PD-L1 CAR-T (Chinese People's Liberation Army General Hospital) 相关的临床结果
100 项与 Anti-BCMA|PD-L1 CAR-T (Chinese People's Liberation Army General Hospital) 相关的转化医学
100 项与 Anti-BCMA|PD-L1 CAR-T (Chinese People's Liberation Army General Hospital) 相关的专利(医药)
100 项与 Anti-BCMA|PD-L1 CAR-T (Chinese People's Liberation Army General Hospital) 相关的药物交易